Defining Progression Free Survival After Multiple Lines of Therapy and Impact of Dynamic Changes in FLIPI for Multiply Relapsed Follicular Lymphoma in the Rituximab Era Treated at Memorial Sloan Kettering Cancer Center (MSKCC)

Despite improved outcomes, Follicular lymphoma (FL) requires multiple lines of therapy. Outcomes of multiply relapsed and observed patients have not been extensively evaluated.

Source: Clinical Lymphoma, Myeloma and Leukemia - September 1, 2017 Category: Hematology Authors: Anna Alperovich, Connie Batlevi, Katy Smith, Zhitao Ying, Philip Caron, Pamela Drullinsky, John Gerecitano, Audrey Hamilton, Paul Hamlin, Steve Horwitz, Anita Kumar, Mathew Matasar, Alison Moskowitz, Craig Moskowitz, Ariela Noy, Maria Lia Palomba, Carol P Source Type: research